Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD finds support for Kinoko AHCC claims

This article was originally published in The Tan Sheet

Executive Summary

The mushroom-derived ingredient active hexose correlated compound shows immune-support benefits, though Quality of Life Labs should tweak its advertising language for Kinoko AHCC and Kinoko AHCC Gold, the National Advertising Division finds. The Purchase, N.Y.-based firm should clarify that data showing improved immune response and enhanced macrophage and T-cell activity are associated with the ingredient and not its products, the Council of Better Business Bureaus unit said May 28. Additionally, Quality of Life should revise its claim that the supplement is supported by "over 80 research studies," since NAD found the actual number was much lower, and should disclose that the immune benefits studied occurred in individuals with compromised immune systems. The company praised NAD's conclusions as "accurate and insightful" and said it will comply

You may also be interested in...



Another EU MDR Notified Body In The Netherlands

Last week, the Commission  revealed that three more notified bodies had been designated; but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.

Sales Already Growing As Vascepa Secures Cardio Approval

Company forecast 2020 sales as high as $700m as regulator grants broad label.

Belgium Outlaws OTC Cough And Cold Combination Drugs

Safety concerns prompt Belgium's drug regulator to order all OTC fixed combination products for coughs and colds removed from shelves.

Topics

UsernamePublicRestriction

Register

PS102969

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel